WebMar 9, 2015 · Autologous hematopoietic cell transplantation (auto-HCT) is a standard consolidation therapy for plasma cell myeloma (PCM). Auto-HCT was associated with superior PFS and OS in two large randomized ... WebUse this page to view details for the decision Memo for Autologous Stem Cell Transplantation (AuSCT) for Multiple Myeloma (CAG-00011R). The page could not be loaded. The CMS.gov Web site currently does not …
Tandem Autologous Stem Cell Transplantation Improves …
WebStem cell transplant is commonly used to treat multiple myeloma. Before the transplant, drug treatment is used to reduce the number of myeloma cells in the patient’s body. … WebDec 10, 2024 · A 57-year-old woman with multiple myeloma (MM) has completed initial therapy with lenalidomide, bortezomib, and dexamethasone, followed by high-dose melphalan and autologous stem cell transplant (auto-SCT). She initially presented with anemia with hemoglobin of 6.1 g/dL, and the disease was staged as Revised … read journal free
The outcome of high-dose chemotherapy and auto-SCT in …
WebFeb 2, 2015 · Incorporation of novel agents into auto-SCT for patients with multiple myeloma has led to improvement in their outcomes. However, the effects of new drugs, either single or combined, on PBSC ... WebOct 11, 2024 · Study Title: Phase III Study of Daratumumab/rHuPh20 plus Lenalidomide or Lenalidomide as Post-Autologous Stem Cell Transplant Maintenance Therapy in Patients with Multiple Myeloma Using Minimal Residual Disease to Direct Therapy Duration (DRAMMATIC Study, S1803) Clinicaltrials.Gov Identifier: NCT04071457 WebThe treatment of monoclonal Ig deposition disease (MIDD) is controversial and not standardized. We report our experience with high dose melphalan and auto-SCT (HDM/auto-SCT) in seven patients with MIDD associated with underlying Durie-Salmon stage IB multiple myeloma, including five with light chain deposition disease, one with … how to stop screen from going dark